Higuchi T, Kinoshita A, Takahashi K, Oda S, Ishikawa I
Department of Periodontology, Faculty of Dentistry, Tokyo Medical and Dental University, Japan.
J Periodontol. 1999 Sep;70(9):1026-31. doi: 10.1902/jop.1999.70.9.1026.
Bone defects and irregularities are major problems for dental implant and periodontal therapies.
We investigated whether the application of recombinant human bone morphogenetic protein-2 (rhBMP-2) induces bone formation in through-and-through bone defects in the rat mandible. A round through-and-through bone defect (5 mm in diameter) was created in the angle of the mandible on both sides of the jaw using a steel round bur in each of 8 Long-Evans rats. In the experimental group, polylactic acid-polyglycolic acid copolymer/gelatin sponge (PGS) containing rhBMP-2 (6 microg/60 microl) was inserted in the bone defect. In the control group, the same carrier without rhBMP-2 was applied in the bone defect on the opposite side. Four weeks after application, the rats were sacrificed. Step serial sections stained with hematoxylin and eosin at intervals of 200 microm were prepared in a bucco-lingual direction. The size of the bone defects and new bone formation were evaluated histometrically.
In all cases in the experimental group, a large quantity of newly formed bone was observed. The bone defects were completely filled with new bone in 4 of 8 rats in the experimental group. In the control group, small amounts of new bone formation were observed along the border of the original mandibular bone. Histometrical analysis revealed that the amount of new bone was significantly larger in the rhBMP-2 treated sites than in the control sites (P <0.0001; paired t-test).
These results indicate that the rhBMP-2/PGS system induced effective bone regeneration on mandibular defects in rats. This procedure may be suitable as an experimental model for bone regeneration using various growth factors and effective for alveolar ridge augmentation followed by dental implant surgery.
骨缺损和骨不规整是牙种植和牙周治疗中的主要问题。
我们研究了重组人骨形态发生蛋白-2(rhBMP-2)应用于大鼠下颌骨贯通性骨缺损时是否能诱导骨形成。使用钢质圆钻在8只Long-Evans大鼠双侧下颌角制造一个圆形贯通性骨缺损(直径5毫米)。在实验组,将含rhBMP-2(6微克/60微升)的聚乳酸-聚乙醇酸共聚物/明胶海绵(PGS)植入骨缺损处。在对照组,将不含rhBMP-2的相同载体应用于对侧骨缺损处。应用四周后,处死大鼠。沿颊舌方向每隔200微米制备苏木精和伊红染色的连续切片。通过组织形态计量学评估骨缺损大小和新骨形成情况。
实验组所有病例均观察到大量新形成的骨组织。实验组8只大鼠中有4只骨缺损被新骨完全填充。对照组在原下颌骨边缘观察到少量新骨形成。组织形态计量学分析显示rhBMP-2处理部位新骨量显著大于对照组(P<0.0001;配对t检验)。
这些结果表明rhBMP-2/PGS系统可诱导大鼠下颌骨缺损有效骨再生。该方法可能适合作为使用各种生长因子进行骨再生的实验模型,并且对牙种植手术前的牙槽嵴增高有效。